3
1. 9. 2024.
A comprehensive review of PRAME and BAP1 in melanoma: Genomic instability and immunotherapy targets.
A comprehensive review of PRAME and BAP1 in melanoma: Genomic instability and immunotherapy targets.
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više